Pfizer (PFE) Tops Q2 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $28.67 +0.92%
Revenue Growth %: -4.6%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: -4.6%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $0.77, $0.09 better than the analyst estimate of $0.68. Revenue for the quarter came in at $15.03 billion versus the consensus estimate of $14.42 billion.
GUIDANCE:
Pfizer sees FY2026 EPS of $2.80-$3.00, versus the consensus of $2.95.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
- Pentagon-Backed Oil Company Is Set to Vie for Chevron's Crown in Venezuela - WSJ
- Bimegren Energy (BESS) files $100M mixed shelf
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
